Samsung Pharmaceutical Files Criminal Complaint Against Company for Trademark Infringement

[Asia Economy Reporter Hyungsoo Park] Samsung Pharmaceutical has decided to take strong measures, including criminal complaints, against the act of company name infringement.

Samsung Pharmaceutical revealed on the 12th that it has filed complaints with the Bundang Police Station and Busan Haeundae Police Station for violations of the Unfair Competition Prevention and Trade Secret Protection Act against companies that sold products similar to its own while labeling the company name as Samsung Pharmaceutical or selling them as if manufactured by Samsung Pharmaceutical.

Earlier, Samsung Pharmaceutical sent a certified letter requesting the cessation of unfair practices to prevent consumer damage caused by company name infringement and similar trademarks.

The accused company had signed a distribution contract with Samsung Pharmaceutical Healthcare, a subsidiary of Samsung Pharmaceutical, and sold products. Samsung Pharmaceutical Healthcare judged that the accused company had infringed the trademark and falsified the manufacturing cost table for some products, leading to the termination of the distribution contract. Even after the termination of the distribution contract, the accused company sold products similar to Samsung Pharmaceutical’s products while using the Samsung Pharmaceutical company name.

A Samsung Pharmaceutical official said, "Around 2020, we received consumer complaints about products with infringed company names and began to identify the status of company name infringement."

He added, "Founded in 1929, Samsung Pharmaceutical is a pharmaceutical company with a distinguished tradition, and we plan to respond strongly to companies that sell similar products under a similar company name."

Samsung Pharmaceutical products can be verified through genuine product certification stickers and the Samsung Pharmaceutical Consumer Center.

This content was produced with the assistance of AI translation services.